Pirenzepine exhibits anti-prostate cancer activity and enhances checkpoint inhibitor-based immunotherapy by targeting STING

Jun Xu(Shanxi Medical University), Yongsheng Yu(Second Affiliated Hospital of Guangzhou Medical University)
European journal of medical research
December 23, 2025
Cited by 0


Related Papers